This inventor holds 4 USPTO granted patents. Top assignee: The Upjohn Co.. Active years: 1976-1977.
Company Filing History:
Years Active: 1976-1977
Title: Innovations of Charles E Coverdale
Introduction
Charles E Coverdale is a notable inventor based in Portage, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating hypertension and anxiety. With a total of 4 patents, Coverdale's work has had a meaningful impact on medical science.
Latest Patents
Among his latest patents, Coverdale has developed compositions and methods using quinolylaminobenzoylpiperazino-1-oxides. These novel compounds are designed to treat hypertension and anxiety in mammals, including humans. The compounds are characterized by specific chemical structures, where R1 can be halogen, lower alkyl, or trifluoromethyl, R2 can be lower alkyl, substituted or unsubstituted phenyl or benzyl, and R3 is hydrogen. Additionally, he has patented p-(trifluoromethylquinolylamino)benzamides, which are useful for systemic administration to achieve antihypertensive and anti-anxiety effects.
Career Highlights
Coverdale has been associated with The Upjohn Company, where he has utilized his expertise in pharmaceutical development. His innovative approaches have led to advancements in the treatment options available for patients suffering from hypertension and anxiety.
Collaborations
Throughout his career, Coverdale has collaborated with notable coworkers such as Louis L Skaletzky and Robert James Collins. These partnerships have contributed to the successful development of his patented compounds.
Conclusion
Charles E Coverdale's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare solutions. His patents reflect a dedication to addressing critical health issues, particularly in the realm of mental and cardiovascular health.